- Home
- RPRX vs JLL Comparison
RPRX vs JLL Comparison
Compare RPRX & JLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- JLL
- Stock Information
- Founded
- RPRX 1996
- JLL 1997
- Country
- RPRX United States
- JLL United States
- Employees
- RPRX N/A
- JLL N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- JLL Real Estate
- Sector
- RPRX Health Care
- JLL Finance
- Exchange
- RPRX Nasdaq
- JLL Nasdaq
- Market Cap
- RPRX 14.2B
- JLL 13.1B
- IPO Year
- RPRX 2020
- JLL 1997
- Fundamental
- Price
- RPRX $31.03
- JLL $222.97
- Analyst Decision
- RPRX Strong Buy
- JLL Strong Buy
- Analyst Count
- RPRX 5
- JLL 7
- Target Price
- RPRX $41.60
- JLL $309.00
- AVG Volume (30 Days)
- RPRX 4.7M
- JLL 323.4K
- Earning Date
- RPRX 05-08-2025
- JLL 05-05-2025
- Dividend Yield
- RPRX 2.77%
- JLL N/A
- EPS Growth
- RPRX N/A
- JLL 141.97
- EPS
- RPRX 1.91
- JLL 11.30
- Revenue
- RPRX $2,263,576,000.00
- JLL $23,432,900,000.00
- Revenue This Year
- RPRX $34.04
- JLL $11.62
- Revenue Next Year
- RPRX $6.10
- JLL $7.37
- P/E Ratio
- RPRX $16.63
- JLL $20.53
- Revenue Growth
- RPRX N/A
- JLL 12.87
- 52 Week Low
- RPRX $24.05
- JLL $171.45
- 52 Week High
- RPRX $34.20
- JLL $288.50
- Technical
- Relative Strength Index (RSI)
- RPRX 36.17
- JLL 30.67
- Support Level
- RPRX $30.82
- JLL $240.99
- Resistance Level
- RPRX $31.85
- JLL $252.10
- Average True Range (ATR)
- RPRX 0.76
- JLL 7.48
- MACD
- RPRX -0.25
- JLL -2.12
- Stochastic Oscillator
- RPRX 9.57
- JLL 2.07
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $74 billion for clients across diverse public and private real estate strategies.